Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.alembiclimited.com | |
Market Cap | 2,351.61 Cr. | |
Enterprise Value(EV) | 2,353.44 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 9.53 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 9.61 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 42.15 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 82.93 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 1.10 | Calculated using Price: 91.58 |
Dividend Yield | 2.40 | Period Ending 2023-03 |
No. of Shares Subscribed | 25.68 Cr. | 256,781,828 Shares |
FaceValue | 2 | |
About Alembic Ltd. | ||
Alembic Ltd. is engaged in the businesses of Pharmaceuticals, Real Estate, and Power Assets. The company was started in 1907 as the flagship company of the Alembic Group. In 2010, the company demerged its core pharmaceutical business (formulations) into a wholly-owned subsidiary, Alembic Pharmaceuticals Ltd. and after the demerger, APL became the flagship company of the Alembic Group. |
1 Day |
|
-1.26% |
1 Week |
|
-3.49% |
1 Month |
|
-1.52% |
3 Month |
|
-4.67% |
6 Month |
|
+14.76% |
1 Year |
|
+46.96% |
2 Year |
|
+17.77% |
5 Year |
|
+120.51% |
10 Year |
|
+404.19% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 5.58 | 3.71 | 3.21 | 4.18 | 3.58 | 7.08 | 0.75 | 3.6 | 3.52 | |
Return on Capital Employed (%) | 3.82 | 3.82 | 3.12 | 4.44 | 3.91 | 7.12 | 0.94 | 4.1 | 3.82 | |
Return on Assets (%) | 2.88 | 3.25 | 2.94 | 3.88 | 3.39 | 6.8 | 0.71 | 3.42 | 3.33 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 528 | 803 | 911 | 1,086 | 1,209 | 1,418 | 2,297 | 2,497 | 2,078 | 2,120 | |
Non Curr. Liab. | 38 | 15 | 13 | 14 | 9 | 7 | 53 | 68 | 43 | 50 | |
Curr. Liab. | 82 | 58 | 68 | 59 | 49 | 46 | 59 | 68 | 84 | 100 | |
Minority Int. | |||||||||||
Equity & Liab. | 648 | 876 | 992 | 1,159 | 1,266 | 1,471 | 2,409 | 2,632 | 2,205 | 2,270 | |
Non Curr. Assets | 458 | 706 | 801 | 972 | 1,167 | 1,308 | 2,307 | 2,489 | 2,032 | 2,130 | |
Curr. Assets | 189 | 169 | 191 | 185 | 99 | 163 | 102 | 143 | 172 | 140 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 648 | 876 | 992 | 1,159 | 1,266 | 1,471 | 2,409 | 2,632 | 2,205 | 2,270 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 144 | 128 | 147 | 125 | 124 | 74 | 74 | 78 | 127 | 146 | |
Other Income | 22 | 29 | 31 | 37 | 30 | 94 | 11 | 89 | 64 | 55 | |
Total Income | 166 | 156 | 178 | 162 | 154 | 167 | 84 | 167 | 192 | 200 | |
Total Expenditure | -135 | -122 | -140 | -114 | -106 | -71 | -63 | -64 | -87 | -99 | |
PBIDT | 30 | 35 | 38 | 48 | 48 | 97 | 21 | 103 | 105 | 101 | |
Interest | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | |
Depreciation | -6 | -6 | -5 | -4 | -3 | -3 | -4 | -5 | -7 | -8 | |
Taxation | 1 | -1 | 1 | -2 | -4 | 0 | -3 | -12 | -6 | -5 | |
Exceptional Items | -3 | -6 | -11 | -11 | |||||||
PAT | 24 | 25 | 27 | 42 | 41 | 93 | 14 | 86 | 81 | 76 | |
Minority Interest | |||||||||||
Share Associate | 82 | 210 | 118 | 121 | 172 | 236 | 329 | 136 | 110 | 168 | |
Other Related Items | |||||||||||
Consolidated Net Profit | 107 | 235 | 145 | 163 | 213 | 329 | 343 | 222 | 191 | 245 | |
Adjusted EPS | 4 | 9 | 5 | 6 | 8 | 13 | 13 | 9 | 7 | 10 |
Particulars | 10 years | 2010-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 149 | 22 | 10 | 52 | 24 | 22 | 7 | -2 | -18 | 39 | |
Cash Fr. Inv. | -24 | 5 | -5 | -47 | -22 | 72 | 57 | -35 | 19 | 7 | |
Cash Fr. Finan. | -118 | -25 | -5 | -5 | -3 | -92 | -6 | -15 | -6 | -46 | |
Net Change | 7 | 2 | 0 | 0 | -1 | 1 | 57 | -52 | -5 | 0 | |
Cash & Cash Eqvt | 24 | 3 | 2 | 2 | 1 | 2 | 59 | 6 | 1 | 1 |
Fri, 03 May 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Please find enclosed herewith the intimation dated 3rd May 2024 received from Link Intime India Private Limited Registrar and Share Transfer Agent regarding lost/misplaced share certificate(s) of the Company for which the shareholder has requested duplicate share certificate(s). |
Fri, 03 May 2024
Board Meeting Intimation for Considering Audited Financial Results For The Quarter And Financial Year Ended 31St March 2024 ALEMBIC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2024 inter alia to consider and approve 1. Audited financial results of the Company for the quarter and financial year ended 31st March 2024 and 2. To recommend dividend on Equity share if any for the financial year ended 31st March 2024. |
Thu, 02 May 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Please find enclosed herewith the intimation dated 2nd May 2024 received from Link Intime India Private Limited Registrar and Share Transfer Agent regarding lost/misplaced share certificate(s) of the Company for which the shareholder has requested duplicate share certificate(s). |
Fri, 03 May 2024 |
Closing Below Previous Low |
Making Lower Lows for 3 days |
Close Within 52 Week High Zone |
Making Lower Lows for 2 Days |
High Increase in 1 Year |